抗肿瘤药物临床试验统计学设计指导原则(征求意见稿)

2020-07-17 国家药品监督管理局药品审评中心(CDE) CDE

为了促进药物临床试验各相关方对抗肿瘤药物临床试验统计学设计的理解与合理应用,经广泛调研和讨论,我中心组织起草了《抗肿瘤药物临床试验统计学设计指导原则(征求意见稿)》。

中文标题:

抗肿瘤药物临床试验统计学设计指导原则(征求意见稿)

发布日期:

2020-07-17

简要介绍:

为了促进药物临床试验各相关方对抗肿瘤药物临床试验统计学设计的理解与合理应用,经广泛调研和讨论,我中心组织起草了《抗肿瘤药物临床试验统计学设计指导原则(征求意见稿)》。
       我们诚挚地欢迎社会各界对征求意见稿提出宝贵意见和建议,并及时反馈给我们,以便后续完善。征求意见时限为自发布之日起1个月。
       您的反馈意见请发到以下联系人的邮箱:
       联系人:潘建红、李若冰
       联系方式:panjh@cde.org.cn,lirb@cde.org.cn
       感谢您的参与和大力支持。
                                                                                                                           国家药品监督管理局药品审评中心
                                                                                                                                         2020年7月17日

评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=965676, encodeId=73c29656e6aa, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388e5381768, createdName=ms7000001395190706, createdTime=Fri May 14 21:08:32 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806074, encodeId=aa3e8060e45f, content=学习了,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8045408687, createdName=迈迪特, createdTime=Tue Aug 04 10:10:16 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2021-05-14 ms7000001395190706

    点赞

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=965676, encodeId=73c29656e6aa, content=点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388e5381768, createdName=ms7000001395190706, createdTime=Fri May 14 21:08:32 CST 2021, time=2021-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806074, encodeId=aa3e8060e45f, content=学习了,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a8045408687, createdName=迈迪特, createdTime=Tue Aug 04 10:10:16 CST 2020, time=2020-08-04, status=1, ipAttribution=)]
    2020-08-04 迈迪特

    学习了,

    0